Stockholders' Equity

3 Months Ended

Mar. 31, 2026

Equity [Abstract]

Stockholders' Equity

Stockholders' Equity

A.Common Stock

We pay monthly distributions to our common stockholders. The following is a summary of monthly distributions paid per common share for the periods indicated below:

	Three months ended March 31,
Month	2026		2025
January	$	0.2700	$	0.2640
February	0.2700		0.2640
March	0.2700		0.2680
Total	$	0.8100	$	0.7960

As of March 31, 2026, a distribution of $0.2705 per common share was payable and was paid in April 2026.

B.    At-the-Market ("ATM") Program

Under our current ATM program, we may offer and sell up to 150.0 million shares of common stock (1) by us to, or through, a consortium of banks acting as our sales agents or (2) by a consortium of banks acting as forward sellers on behalf of any forward purchasers contemplated thereunder, in each case by means of ordinary brokers' transactions on the NYSE under the ticker symbol "O" at prevailing market prices or at negotiated prices. Upon settlement, subject to certain exceptions, we may elect, in our sole discretion, to cash settle or net share settle all or any portion of our obligations under any forward sale agreement, in which cases we may not receive any proceeds (in the case of cash settlement) or will not receive any proceeds (in the case of net share settlement), and we may owe cash (in the case of cash settlement) or shares of our common stock (in the case of net share settlement) to the relevant forward purchaser. As of March 31, 2026, we had 132.9 million shares remaining for future issuance under our ATM program. We anticipate maintaining the availability of our ATM program in the future, including the replenishment of authorized shares issuable thereunder.

The following table outlines common stock issuances pursuant to our ATM programs (dollars in millions, shares in thousands):

	Three months ended March 31,
	2026		2025
Shares of common stock issued under the ATM program (1)	—		11,231
Gross proceeds	$	—	$	632.0
Sales agents' commissions and other offering expenses	(0.2)		(7.2)
Net proceeds	$	(0.2)	$	624.8

(1) During the three months ended March 31, 2026, 8.2 million shares were sold, and no shares were settled pursuant to forward sale confirmations. As of March 31, 2026, 20.8 million shares of common stock subject to forward sale confirmations have been executed, but not settled, at a weighted average initial gross price of $60.07 per share. We currently expect to fully settle forward sale agreements outstanding by June 30, 2026, representing $1.2 billion in net proceeds, for which the weighted average forward price as of March 31, 2026 was $58.63 per share.

C.    Dividend Reinvestment and Stock Purchase Plan ("DRSPP")

Our DRSPP provides our common stockholders with a convenient and economical method of purchasing our common stock and reinvesting their distributions. It also allows our current stockholders to buy additional shares of common stock by reinvesting all or a portion of their distributions. Our DRSPP authorizes up to 26.0 million common shares to be issued. As of March 31, 2026, we had 10.5 million shares remaining for future issuance under our DRSPP program.

The following table outlines common stock issuances pursuant to our DRSPP program (dollars in millions, shares in thousands):

	Three months ended March 31,
	2026		2025
Shares of common stock issued under the DRSPP program	50		57
Gross proceeds	$	3.1	$	3.1

D.    Repurchases of Common Stock

We repurchased 1.8 million shares of our common stock during the three months ended March 31, 2026 for an aggregate cost of $101.9 million. As of March 31, 2026, there was $1.9 billion remaining under the share repurchase program authorized by the Board of Directors, which expires in January 2028.